ArticleTranslational vision science & technology2026
The Inter-Eye Differences of the Circumpapillary Microvasculature in Primary Open-Angle Glaucoma.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess inter-eye differences of circumpapillary vessel density (cpVD) in patients with primary open-angle glaucoma (POAG) and elucidate factors implicated in glaucomatous vascular pathology. Methods: POAG subjects and controls underwent optical coherence tomography (OCT) and OCT angiography (OCTA) imaging in both eyes. Inter-eye differences of OCT, OCTA, visual field (VF) and other ophthalmic parameters were assessed. Results: Seventy-two POAG subjects and 53 controls were similar in age, gender, and visual acuity (P ≥ 0.28 for all). POAG subjects had greater retinal nerve fiber layer (RNFL) asymmetry than controls (10 ± 10 µm vs. 5 ± 5 µm, P < 0.001). POAG patients also demonstrated significantly asymmetric mean deviation (MD) between the worse (-5.2 ± 4.0 dB) and better eye (-1.5 ± 2.6 dB, P < 0.001). However, POAG subjects had similar inter-eye cpVD asymmetry compared to controls (3.5% ± 2.6% vs. 3.1% ± 1.9%, respectively; P = 0.32). In a multivariable regression, MD asymmetry was associated with greater RNFL asymmetry (β = 0.540; 95% confidence interval [CI], 0.249-0.830; P < 0.001), whereas treated systemic hypertension (β = -0.415; 95% CI, -0.679 to -0.151; P < 0.001) was associated with decreased cpVD asymmetry in POAG subjects. Conclusions: POAG subjects demonstrated greater inter-eye RNFL asymmetry than controls, but similar cpVD asymmetry. Although RNFL asymmetry was associated with difference in VF, inter-eye difference of circumpapillary microvasculature was minimized by systemic hypertension treatment, supporting systemic determinants of glaucomatous vascular pathology. Translational Relevance: Our findings highlight a discordance in vascular pathology and structural RNFL damage between eyes in POAG, suggesting a systemic predisposition of vascular pathology in POAG.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.